Document Details
Form
Filing Date
April 28, 2022
Document Date
April 26, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
